Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-15 Sale | 2026-07-17 1:15 pm | Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO | 25,000 | $4.0077 | $100,192 | 610,574 (Direct) | View |
| 2026-06-23 Sale | 2026-06-24 11:11 am | Aquestive Therapeutics Inc. | AQST | Krop Julie Director | 25,000 | $5.0157 | $125,393 | 0 (Direct) | View |
| 2026-06-15 Sale | 2026-06-16 4:09 pm | Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO | 25,000 | $4.1604 | $104,010 | 635,574 (Direct) | View |
| 2026-05-15 Sale | 2026-05-18 2:03 pm | Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO | 8,257 | $4.2889 | $35,413 | 660,574 (Direct) | View |
| 2026-03-10 Sale | 2026-03-11 12:52 pm | Aquestive Therapeutics Inc. | AQST | Boyd Peter E. Chief People Officer | 29,814 | $4.173 | $124,414 | 381,009 (Direct) | View |
| 2026-03-10 Sale | 2026-03-11 12:52 pm | Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO | 180,677 | $4.173 | $753,965 | 1,527,753 (Direct) | View |
| 2026-03-10 Sale | 2026-03-11 12:52 pm | Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J Chief Legal Officer | 40,102 | $4.173 | $167,346 | 492,879 (Direct) | View |
| 2026-03-10 Sale | 2026-03-11 12:52 pm | Aquestive Therapeutics Inc. | AQST | Cioffi Melina SVP, Regulatory Affairs | 25,311 | $4.173 | $105,623 | 349,867 (Direct) | View |
| 2026-03-10 Sale | 2026-03-11 12:51 pm | Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR Chief Financial Officer | 58,254 | $4.173 | $243,094 | 446,112 (Direct) | View |
| 2026-03-10 Sale | 2026-03-11 12:51 pm | Aquestive Therapeutics Inc. | AQST | Korczynski Sherry Chief Commercial Officer | 15,741 | $4.173 | $65,687 | 283,617 (Direct) | View |
| 2026-03-10 Sale | 2026-03-11 12:50 pm | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 45,791 | $4.173 | $191,086 | 319,480 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-23 Exercise | 2026-06-24 11:11 am | N/A 2032-06-22 | Aquestive Therapeutics Inc. | AQST | Krop Julie Director | 25,000 | $0 | 0 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-24 11:11 am | N/A N/A | Aquestive Therapeutics Inc. | AQST | Krop Julie Director | 25,000 | $0.7132 | 0 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-12 11:43 am | 2027-06-10 2036-06-10 | Aquestive Therapeutics Inc. | AQST | MORRIS TIMOTHY E Director | 50,500 | $0 | 50,500 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-12 11:43 am | 2027-06-10 2036-06-10 | Aquestive Therapeutics Inc. | AQST | Krop Julie Director | 50,500 | $0 | 50,500 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-12 11:42 am | 2027-06-10 2036-06-10 | Aquestive Therapeutics Inc. | AQST | Jenkins Abigail L. Director | 50,500 | $0 | 50,500 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-12 11:42 am | 2027-06-10 2036-06-10 | Aquestive Therapeutics Inc. | AQST | Cochran John Director | 50,500 | $0 | 149,986 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-12 11:42 am | 2027-06-10 2036-06-10 | Aquestive Therapeutics Inc. | AQST | BROWN GREGORY B Director | 50,500 | $0 | 125,585 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-12 11:42 am | 2027-06-10 2036-06-10 | Aquestive Therapeutics Inc. | AQST | Taglietti Marco Director | 50,500 | $0 | 50,500 (Direct) | View |
| 2026-06-08 Tax Withholding | 2026-06-09 2:48 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Korczynski Sherry Chief Commercial Officer | 2,714 | $0 | 238,403 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-19 12:02 pm | N/A 2036-05-08 | Aquestive Therapeutics Inc. | AQST | Zalewski Thomas A. Chief Legal Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2026-05-15 Tax Withholding | 2026-05-18 12:36 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Cioffi Melina SVP, Regulatory Affairs | 1,667 | $4.17 | 273,200 (Direct) | View |
| 2026-05-07 Tax Withholding | 2026-05-11 4:35 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J Corporate Secretary | 135,690 | $4.23 | 231,042 (Direct) | View |
| 2026-05-05 Tax Withholding | 2026-05-07 5:34 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Boyd Peter E. Chief People Officer | 56,778 | $4.18 | 281,731 (Direct) | View |
| 2026-05-05 Tax Withholding | 2026-05-07 5:33 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO | 335,922 | $4.18 | 668,831 (Direct) | View |
| 2026-05-05 Tax Withholding | 2026-05-07 5:33 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR Chief Financial Officer | 92,652 | $4.18 | 283,460 (Direct) | View |
| 2026-05-05 Tax Withholding | 2026-05-07 5:32 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 72,734 | $4.18 | 204,246 (Direct) | View |
| 2026-05-05 Tax Withholding | 2026-05-07 5:31 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J Corporate Secretary | 76,147 | $4.18 | 366,732 (Direct) | View |
| 2025-03-07 Option Award | 2026-04-13 3:54 pm | N/A 2028-03-07 | Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO | 293,100 | $0 | 293,100 (Direct) | View |
| 2025-03-07 Option Award | 2026-04-13 3:54 pm | N/A 2028-03-07 | Aquestive Therapeutics Inc. | AQST | Boyd Peter E. Chief People Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2025-03-07 Option Award | 2026-04-13 3:53 pm | N/A 2028-03-07 | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2025-03-07 Option Award | 2026-04-13 3:52 pm | N/A 2028-03-07 | Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR SVP, Chief Financial Officer | 82,500 | $0 | 82,500 (Direct) | View |
| 2025-03-07 Option Award | 2026-04-13 3:52 pm | N/A 2028-03-07 | Aquestive Therapeutics Inc. | AQST | Korczynski Sherry Chief Commercial Officer | 67,500 | $0 | 67,500 (Direct) | View |
| 2025-03-07 Option Award | 2026-04-13 3:51 pm | N/A 2028-03-07 | Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J Corporate Secretary | 82,500 | $0 | 82,500 (Direct) | View |
Ownership | 2026-04-10 09:56 am | N/A N/A | Aquestive Therapeutics Inc. | AQST | Zalewski Thomas A. Chief Legal Officer | 0 | $0 | 0 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:52 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Boyd Peter E. Chief People Officer | 80,000 | $0 | 381,009 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:52 pm | N/A 2036-03-09 | Aquestive Therapeutics Inc. | AQST | Boyd Peter E. Chief People Officer | 42,500 | $4.29 | 381,009 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:52 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO | 262,000 | $0 | 1,527,753 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:52 pm | N/A 2036-03-09 | Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO | 523,000 | $4.29 | 1,527,753 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:52 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J Chief Legal Officer | 80,000 | $0 | 492,879 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:52 pm | N/A 2036-03-09 | Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J Chief Legal Officer | 50,000 | $4.29 | 492,879 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:52 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Cioffi Melina SVP, Regulatory Affairs | 100,000 | $0 | 349,867 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:52 pm | N/A 2036-03-09 | Aquestive Therapeutics Inc. | AQST | Cioffi Melina SVP, Regulatory Affairs | 75,000 | $4.29 | 349,867 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:51 pm | N/A 2036-03-09 | Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR Chief Financial Officer | 165,000 | $0 | 446,112 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:51 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Korczynski Sherry Chief Commercial Officer | 75,000 | $0 | 283,617 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:51 pm | N/A 2036-03-09 | Aquestive Therapeutics Inc. | AQST | Korczynski Sherry Chief Commercial Officer | 42,500 | $4.29 | 283,617 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:50 pm | N/A 2036-03-09 | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 122,500 | $0 | 319,480 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:49 pm | N/A 2036-03-09 | Aquestive Therapeutics Inc. | AQST | Davis Matthew W. Chief Development Officer | 50,000 | $0 | 150,000 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 09:25 am | N/A N/A | Aquestive Therapeutics Inc. | AQST | Greenhawt Matthew J. Chief Medical Officer | 75,000 | $0 | 127,000 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 09:25 am | N/A 2036-03-09 | Aquestive Therapeutics Inc. | AQST | Greenhawt Matthew J. Chief Medical Officer | 50,000 | $4.29 | 127,000 (Direct) | View |
Ownership | 2026-03-11 09:19 am | N/A N/A | Aquestive Therapeutics Inc. | AQST | Greenhawt Matthew J. Chief Medical Officer | 0 | $0 | 2,000 (Indirect) | View |
| 2025-12-04 Option Award | 2025-12-05 1:06 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Boyd Peter E. Chief People Officer | 20,000 | $0 | 288,323 (Direct) | View |
| 2025-12-02 Tax Withholding | 2025-12-04 10:39 am | N/A N/A | Aquestive Therapeutics Inc. | AQST | Cioffi Melina SVP, Regulatory Affairs | 2,083 | $5.93 | 200,178 (Direct) | View |
| 2025-11-10 Option Award | 2025-11-12 09:35 am | N/A 2035-11-10 | Aquestive Therapeutics Inc. | AQST | Davis Matthew W. Chief Development Officer | 50,000 | $0 | 100,000 (Direct) | View |